Vistagen Therapeutics, Inc. (VTGN)

Last Year

22-Nov-23 -- 21-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

13

0

4

+1

0

+2

0

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Jul-24 6:06 PM View:	28-Jun-24 Grant $14.36K	Singh Shawn CHIEF EXECUTIVE OFFICER Director		Vistagen Therapeutics, Inc. - VTGN	19% 26.34K to 31.36K	0	0	--	--	Show Txns Hide Txns

02-Jul-24 6:08 PM View:	28-Jun-24 Grant $10.63K	Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER		Vistagen Therapeutics, Inc. - VTGN	100% 0 to 3.59K	0	0	--	--	Show Txns Hide Txns

02-Jul-24 6:10 PM View:	28-Jun-24 Grant $7.90K	Prince Joshua S. Chief Operating Officer		Vistagen Therapeutics, Inc. - VTGN	100% 0 to 2.67K	0	0	--	--	Show Txns Hide Txns

02-Jul-24 6:07 PM View:	28-Jun-24 Grant $14.36K	Adler Reid G. CHF CORP DEVEL OFF, GEN COUNS		Vistagen Therapeutics, Inc. - VTGN	44% 11.49K to 16.51K	0	0	--	--	Show Txns Hide Txns